. Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease. IDrugs. 2007 Feb;10(2):121-33. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. This is an exciting story to keep an eye on for outcome of the phase III trial. It would be great to see successful translation of basic science research into more effective therapies for patients.

Make a Comment

To make a comment you must login or register.